4.4 Review

PharmGKB: UNDERSTANDING THE EFFECTS OF INDIVIDUAL GENETIC VARIANTS

期刊

DRUG METABOLISM REVIEWS
卷 40, 期 4, 页码 539-551

出版社

INFORMA HEALTHCARE
DOI: 10.1080/03602530802413338

关键词

Polymorphism; Variant; Drug; Tamoxifen; Warfarin; PharmGKB; Disease; Gene; Pharmacogenetics; Pharmacogenomics

资金

  1. NIH/NIGMS Pharmacogenetics Research Network (PGRN) and Database [U01GM61374]
  2. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The Pharmacogenetics and Pharmacogenomics Knowledge Base (PharmGKB: http://www.pharmgkb.org) is devoted to disseminating primary data and knowledge in pharmacogenetics and pharmacogenomics. We are annotating the genes that are most important for drug response and present this information in the form of Very Important Pharmacogene (VIP) summaries, pathway diagrams, and curated literature. The PharmGKB currently contains information on over 500 drugs, 500 diseases, and 700 genes with genotyped variants. New features focus on capturing the phenotypic consequences of individual genetic variants. These features link variant genotypes to phenotypes, increase the breadth of pharmacogenomics literature curated, and visualize single-nucleotide polymorphisms on a gene's three-dimensional protein structure.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据